{
    "title": "Merck heart drug surprises with positive result; questions linger",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4643470/Mercks-cholesterol-drug-clears-main-goal-late-stage-study.html",
    "date": "2017-06-27",
    "keywords": [
        "heart",
        "drug",
        "cholesterol",
        "trial",
        "class",
        "history",
        "failure",
        "approval",
        "anacetrapib",
        "merck",
        "data",
        "pfizer",
        "bill",
        "berkrot",
        "june",
        "co",
        "tuesday",
        "company",
        "surprise",
        "success",
        "drugmaker",
        "goal",
        "reduction",
        "risk",
        "death",
        "need",
        "repeat",
        "arteryclearing",
        "result",
        "past",
        "statement",
        "application",
        "message",
        "chief",
        "cardiology",
        "cleveland",
        "clinic",
        "cetp",
        "fact",
        "theyre",
        "treatment",
        "effect",
        "meeting",
        "aug",
        "percent",
        "premarket",
        "trading",
        "uncertainty",
        "release",
        "credit",
        "analyst",
        "vamil",
        "divan",
        "decade",
        "ability",
        "hdl",
        "torcetrapib",
        "revenue",
        "lipitor",
        "medicine",
        "patent",
        "protection",
        "plug",
        "phase",
        "program",
        "imbalance",
        "safety",
        "roche",
        "efficacy",
        "ldl",
        "reporting",
        "mukhopadhyay",
        "bengaluru",
        "editing",
        "kalluvila",
        "dan",
        "grebler"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}